Health News

Eli Lilly to invest $450 mln to expand diabetes drug plant capacity

Bengaluru: Eli Lilly and Co said on Tuesday it plans to invest an additional $450 million to expand its manufacturing capacity at the Research Triangle Park facility in North Carolina to support increased demand for its diabetes drugs.

Since 2020, the drugmaker has committed around $4 billion to new manufacturing facilities in North Carolina, including $1.7 billion for the development and expansion of its site at Research Triangle Park.

Follow and connect with us on , facebook, LinkedIn, youtube

Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button